박사

The effect of lupeol, a pentacyclic triterpene, on the treatment of acne : 오환성 트리터핀계 화학물 루페올의 여드름 치료 효과

권혁훈 2015년
논문상세정보
' The effect of lupeol, a pentacyclic triterpene, on the treatment of acne : 오환성 트리터핀계 화학물 루페올의 여드름 치료 효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • acne
  • activity guided purification
  • clinical trial
  • lupeol
  • therapeutic development
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
123 0

0.0%

' The effect of lupeol, a pentacyclic triterpene, on the treatment of acne : 오환성 트리터핀계 화학물 루페올의 여드름 치료 효과' 의 참고문헌

  • Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne?Experimental Dermatology 2005: 14: 143-152.
  • Zhao G, Etherton TD, Martin KR, et al. Anti-inflammatory effects ofpolyunsaturated fatty acids in THP-1 cells. Biochemical and BiophysicalResearch Communications 2005: 336: 909-917.
  • Yoon J Y, Kwon HH, Min SU, et al. Epigallocatechin-3-gallate improves acnein humans by modulating intracellular molecular targets and inhibiting P. acnes.Journal of Investigative Dermatology 2013: 133: 429-440.
  • Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activityand cathelicidin promotes skin inflammation in rosacea. Nature Medicine2007: 13: 975-980.
  • Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012: 379: 361-372.
  • Thiboutot DM, Weiss J, Bucko A, et al. Adapalene-benzoyl peroxide, a fixeddosecombination for the treatment of acne vulgaris: results of a multicenter,randomized double-blind, controlled study. Journal of the American Academyof Dermatology 2007: 57: 791-799.
  • Thiboutot D, Jabara S, McAllister JM, et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normalsebocytes, and an immortalized sebocyte cell line (SEB-1). Journal ofInvestigative Dermatology 2003: 120: 905-914.
  • Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management ofacne: an update from the Global Alliance to Improve Outcomes in Acne group.Journal of the American Academy of Dermatology 2009: 60: S1-50.
  • Tarapore RS, Siddiqui IA, Adhami VM, et al. The dietary terpene lupeol targetscolorectal cancer cells with constitutively active Wnt/beta-catenin signaling.Molecular Nutrition & Food Research 2013: 57: 1950-1958.
  • Tanaka T, Ikeda T, Kaku M, et al. A new lignan glycoside and phenylethanoidglycosides from Strobilanthes cusia BREMEK. Chemical & PharmaceuticalBulletin 2004; 52: 1242-1245.
  • Sudhahar V, Kumar SA, Varalakshmi P. Role of lupeol and lupeol linoleate onlipemic-oxidative stress in experimental hypercholesterolemia. Life Sciences2006: 78: 1329-1335.
  • Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgarismanagement. Journal of the American Academy of Dermatology 2007: 56: 651-663.
  • Srinivasan T, Srivastava G, Pathank A, et al. Solid-phase synthesis andbioevaluation of lupeol-based libraries as antimalarial agents. Bioorganic &Medicinal Chemistry Letters 2002; 12: 2803?2806.
  • Smith TM, Gilliland K, Clawson GA, et al. IGF-1 induces SREBP-1expression and lipogenesis in SEB-1 sebocytes via activation of thephosphoinositide 3-kinase/Akt pathway. Journal of Investigative Dermatology2008: 128: 1286-1293.
  • Siddique HR, Saleem M. Beneficial health effects of lupeol triterpene: a review ofpreclinical studies. Life Sciences 2011: 88: 285-293.
  • Selway JL, Kurczab T, Kealey T, et al. Toll-like receptor 2 activation andcomedogenesis: implications for the pathogenesis of acne. BMC Dermatology2013: 13: 10.
  • Saleem M. Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene.Cancer Letters 2009: 285: 109-115.
  • Saleem M, Kaur S, Kweon MH, et al. Lupeol, a fruit and vegetable basedtriterpene, induces apoptotic death of human pancreatic adenocarcinoma cellsvia inhibition of Ras signaling pathway. Carcinogenesis 2005: 26: 1956-1964.
  • Saleem M, Alam A, Arifin S, et al. Lupeol, a triterpene, inhibits early responses oftumor promotion induced by benzoyl peroxide in murine skin. PharmacologicalResearch 2001: 43: 127-134.
  • Saleem M, Afaq F, Adhami VM, et al. Lupeol modulates NF-kappa B andPI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004:23: 5203-5214.
  • Ramot Y, Sugawara K, Zakany N, et al. A novel control of human keratinexpression: cannabinoid receptor 1-mediated signaling down-regulates theexpression of keratins K6 and K16 in human keratinocytes in vitro and in situ.Peer J 2013: 1: e40.
  • Proniuk S, Liederer BM, Blanchard J. Preformulation study of epigallocatechingallate, a promising antioxidant for topical skin cancer prevention. Journal ofPharmaceutical Sciences 2002: 91: 111-116.
  • Pikarsky E, Porat RM, Stein I, et al. NF-kappa B functions as a tumourpromoter in inflammation-associated cancer. Nature 2004: 431: 461-466.
  • Newman D. Natural products as leads to potential drugs: An old process or thenew hope for drug discovery? Journal of Medical Chemistry 2008; 51: 2589-2599.
  • Nelson AM, Zhao W, Gilliland KL, et al. Neutrophil gelatinase-associatedlipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceousgland cells. Journal of Clinical Investigation 2008: 118: 1468-1478.
  • Nakatsuji T, Kao MC, Zhang L, et al. Sebum free fatty acids enhance the innateimmune defense of human sebocytes by upregulating beta-defensin-2 expression.Journal of Investigative Dermatology 2010; 130: 985-994.
  • Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes andlipopolysaccharide induce the expression of antimicrobial peptides andproinflammatory cytokines/chemokines in human sebocytes. Microbes andInfection 2006: 8: 2195-2205.
  • Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobicsolutes based on four permeation pathways. Journal of Controlled Release 2003:86: 69-92.
  • Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of thesebaceous gland in the pathogenesis of acne. Dermato-Endocrinology 2011: 3:41-49.
  • Liu F, He Y, Liang Y, et al. PI3-kinase inhibition synergistically promoted theanti-tumor effect of lupeol in hepatocellular carcinoma. Cancer CellInternational 2013: 13: 108.
  • Lee WR, Kim KH, An HJ, et al. The protective effects of Melittin onPropionibacterium acnes-induced inflammatory responses in vitro and in vivo.Journal of Investigative Dermatology 2014: 134: 1922-1930.
  • Lee TK, Poon RT, Wo JY, et al. Lupeol suppresses cisplatin-induced nuclearfactor-kappaB activation in head and neck squamous cell carcinoma and inhibitslocal invasion and nodal metastasis in an orthotopic nude mouse model. CancerResearch 2007: 67: 8800-8809.
  • Laszczyk MN. Pentacyclic triterpenes of the lupane, oleanane and ursane groupas tools in cancer therapy. Planta Medica 2009: 75: 1549-1560.
  • Kwon HH, Youn JW, Park SY, et al. Comparison of Clinical and HistologicalEffects between Lactobacillus-Fermented Chamaecyparis Obtusa and Tea TreeOil for the Treatment of Acne: An Eight-Week Double-Blind RandomizedControlled Split-Face Study. Dermatology 2014; 229: 102-109.
  • Kim J. Review of the innate immune response in acne vulgaris: activation ofToll-like receptor 2 in acne triggers inflammatory cytokine responses.Dermatology 2005: 211: 193-198.
  • Kang S, Cho S, Chung JH, et al. Inflammation and extracellular matrixdegradation mediated by activated transcription factors nuclear factor-kappa Band activator protein-1 in inflammatory acne lesions in vivo. American Journalof Pathology 2005: 166: 1691-1699.
  • Ji HF, Li XJ, Zhang HY. Natural products and drug discovery. Can thousands ofyears of ancient medical knowledge lead us to new and powerful drugcombinations in the fight against cancer and dementia? EMBO Reports 2009: 10:194-200.
  • James WD. Clinical practice. Acne. New England Journal of Medicine 2005: 352:1463-1472.
  • Harper JC, Thiboutot DM. Pathogenesis of acne: recent research advances.Advances in Dermatology 2003: 19: 1-10.
  • Harish BG, Krishna V, Santosh Kumar HS, et al. Wound healing activity anddocking of glycogen-synthase-kinase-3-beta-protein with isolated triterpenoidlupeol in rats. Phytomedicine 2008: 15: 763-767.
  • Guy R, Green MR, Kealey T. Modeling acne in vitro. Journal of InvestigativeDermatology 1996: 106: 176-182.
  • Guo C, Gasparian AV, Zhuang Z, et al. 9-Aminoacridine-based anticancerdrugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways. Oncogene2009: 28: 1151-1161.
  • Graham GM, Farrar MD, Cruse-Sawyer JE, et al. Proinflammatory cytokineproduction by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. British Journal of Dermatology 2004: 150: 421-428.
  • Gollnick HP, Draelos Z, Glenn MJ, et al. Adapalene-benzoyl peroxide, aunique fixed-dose combination topical gel for the treatment of acne vulgaris: atransatlantic, randomized, double-blind, controlled study in 1670 patients.British Journal of Dermatology 2009: 161: 1180-1189.
  • Garces R, Mancha M. One-step lipid extraction and fatty acid methyl esterspreparation from fresh plant tissues. Analytical Biochemistry 1993: 211: 139-143.
  • Draelos ZD. Improving compliance in acne treatment: benzoyl peroxideconsiderations. Cutis 2008: 82: 17-20.
  • Ardiansyah, Yamaguchi E, Shirakawa H, et al. Lupeol supplementationimproves blood pressure and lipid metabolism parameters in stroke-pronespontaneously hypertensive rats. Bioscience, Biotechnology, and Biochemistry2012: 76: 183-185.
  • Anadolu RY, Sen T, Tarimci N, et al. Improved efficacy and tolerability ofretinoic acid in acne vulgaris: a new topical formulation with cyclodextrincomplex psi. Journal of the European Academy of Dermatology andVenereology 2004: 18: 416-421.
  • Aldana OL, Holland DB, Cunliffe WJ. Variation in pilosebaceous ductkeratinocyte proliferation in acne patients. Dermatology 1998: 196: 98-99.
  • Ahmed Y, Sohrab MH, Al-Reza SM, et al. Antimicrobial and cytotoxicconstituents from leaves of Sapium baccatum. Food and Chemical Toxicology2010: 48: 549-552.
  • Agak GW, Qin M, Nobe J, et al. Propionibacterium acnes induces an IL-17response in acne culgaris that is regulated by vitamin A and vitamin D. Journalof Investigative Dermatology 2014: 134: 366-373.